Wellington Management Group LLP Has $1.56 Million Stock Holdings in Genpact Limited $G

Key Points

• Wellington Management increased its Genpact position by 270.7% in the second quarter, bringing its holdings to 56,883 shares valued at approximately $1.56 million. Institutional investors and hedge funds collectively own 96.03% of the company.
• Analysts maintain a generally cautious view, with Genpact receiving an average “Hold” rating and an average price target of $39.33. Recent targets range from $31 to $43.
• Genpact shares opened at $35.14, while the company reported quarterly revenue of $1.34 billion and EPS of $1.00. Genpact also declared a quarterly dividend of $0.1875, equivalent to a 2.1% annualized yield.

Wellington Management Group LLP raised its position in Genpact Limited (NYSE:G - Free Report) by 270.7% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 56,883 shares of the business services provider's stock after buying an additional 41,538 shares during the period. Wellington Management Group LLP's holdings in Genpact were worth $1,564,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. AQR Capital Management LLC lifted its stake in shares of Genpact by 90.9% during the fourth quarter. AQR Capital Management LLC now owns 6,575,115 shares of the business services provider's stock valued at $307,584,000 after acquiring an additional 3,131,643 shares during the period. FIL Ltd increased its position in Genpact by 114.4% in the fourth quarter. FIL Ltd now owns 4,802,854 shares of the business services provider's stock worth $224,678,000 after purchasing an additional 2,562,484 shares during the period. Dimensional Fund Advisors LP raised its holdings in Genpact by 26.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 5,010,764 shares of the business services provider's stock worth $234,409,000 after purchasing an additional 1,032,554 shares during the last quarter. Nalanda India Equity Fund Ltd raised its holdings in Genpact by 8.0% during the 4th quarter. Nalanda India Equity Fund Ltd now owns 13,702,500 shares of the business services provider's stock worth $641,003,000 after purchasing an additional 1,015,556 shares during the last quarter. Finally, Millennium Management LLC lifted its position in Genpact by 1,531.9% during the 4th quarter. Millennium Management LLC now owns 1,046,671 shares of the business services provider's stock valued at $48,963,000 after purchasing an additional 982,532 shares during the period. 96.03% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, SVP Anil Nanduru sold 6,191 shares of the company's stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $37.03, for a total value of $229,252.73. Following the completion of the sale, the senior vice president owned 70,253 shares in the company, valued at $2,601,468.59. This represents a 8.10% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.58% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages have recently issued reports on G. BMO Capital Markets reaffirmed a "market perform" rating and issued a $40.00 target price on shares of Genpact in a research note on Friday, August 7th. TD Cowen increased their price objective on shares of Genpact from $42.00 to $43.00 and gave the company a "buy" rating in a report on Friday, August 7th. Weiss Ratings cut shares of Genpact from a "hold (c)" rating to a "hold (c-)" rating in a research note on Wednesday, June 24th. Susquehanna lifted their target price on shares of Genpact from $33.00 to $37.00 and gave the stock a "neutral" rating in a report on Friday, August 7th. Finally, Deutsche Bank Aktiengesellschaft set a $31.00 target price on shares of Genpact in a research report on Friday, July 10th. Two analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat, Genpact presently has an average rating of "Hold" and an average target price of $39.33.

Genpact Stock Performance

Shares of G stock opened at $35.14 on Friday. The stock has a market cap of $5.90 billion, a PE ratio of 10.43, a price-to-earnings-growth ratio of 0.92 and a beta of 0.58. The stock has a 50-day moving average of $34.09 and a 200-day moving average of $34.29. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.00 and a quick ratio of 2.00. Genpact Limited has a one year low of $26.85 and a one year high of $48.64.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Tuesday, June 30th. The business services provider reported $1.00 earnings per share (EPS) for the quarter. Genpact had a net margin of 11.04% and a return on equity of 23.34%. The firm had revenue of $1.34 billion during the quarter. As a group, sell-side analysts expect that Genpact Limited will post 3.66 earnings per share for the current year.

Genpact Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 24th. Stockholders of record on Thursday, September 10th will be issued a $0.1875 dividend. The ex-dividend date of this dividend is Thursday, September 10th. This represents a $0.75 annualized dividend and a dividend yield of 2.1%. Genpact's payout ratio is 22.26%.

Genpact Company Profile

Genpact is a global professional services and technology company that helps organizations transform business processes and improve operational performance. Its services combine artificial intelligence, data and analytics, cloud technologies, digital engineering, and process expertise to support functions such as finance and accounting, procurement, supply chain management, customer care, risk management, and insurance operations.

The company serves clients across industries including banking and capital markets, insurance, healthcare and life sciences, consumer goods and retail, high technology, manufacturing, and professional services.

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.